Monash IVF Group (ASX:MVF) Eyes International Growth, Targets AUD 31M NPAT in FY25

4 min read | April 02, 2025 10:49 PM AEDT | By Team Kalkine Media

Google News:

Monash IVF Group (ASX:MVF) Eyes International Growth, Targets AUD 31M NPAT in FY25 — Image source: sbhutterstock

Recent News

Why Is Insider Activity Putting Lion Rock Minerals Back in Focus?

Should Investors Be Concerned About Insider Selling at Clever Culture...

Can Lendlease’s Australia-First Strategy Rewrite Its Future?

3 ASX ETFs That Could Shape the Next Decade

Make Kalkine Media
My Trusted Source

Highlights

MVF reported an 11.6% YoY increase in revenue to AUD 140.3 million in 1HFY25, driven by acquisitions and pricing strategies.

NPAT rose 34.4% YoY to AUD 17.3 million in 1HFY25.

The company is actively expanding in South-East Asia and improving its presence in Singapore and Kuala Lumpur.

Monash IVF Group Limited (ASX:MVF) is an ASX-listed reproductive and fertility services provider in Australia. In the half-year ended 31 December 2024 (1HFY25), MVF reported revenue of AUD 140.3 million, reflecting an 11.6% year-over-year (YoY) growth from AUD 125.7 million in 1HFY24, supported by domestic IVF acquisition, diversified services and price growth. Net Profit After Tax (NPAT) surged by 34.4% YoY to AUD 17.3 million in 1HFY25, up from AUD 12.9 million in the previous corresponding period.

1HFY25 performance was primarily driven by the revenue and earnings growth across Domestic Assisted Reproductive Services (ARS), Women’s Imaging, and International ARS segments. Despite challenges in the domestic IVF industry, operational cost alignment and the integration of the Fertility North acquisition contributed to EBITDA growth.

Recent Business Updates

MVF recently announced a key business update regarding its substantial holding structure. UniSuper Limited, a trustee for UniSuper and UniSuper Management Pty Limited, ceased to be a substantial holder in Monash IVF Group on 11 March 2025, following a previous notice on 29 January 2025.

Company Outlook

The company aims to drive growth through services such as genetics, donor programs, and egg freezing, which are expected to benefit from rising maternal age trends and evolving patient needs.

MVF is actively expanding into South-East Asia, with acquisitions and new facility developments in Singapore and Kuala Lumpur (KL) to strengthen its market presence.

NPAT is expected to grow to AUD 30.0–31.0 million in FY25.

Share performance of MVF

MVF shares closed 1.34% lower at AUD 1.105 per share on 2 April 2025. Over the past year, MVF’s share price has dropped by almost 22.73% and in three months, it has declined by 12.99%.

52-week high of MVF is AUD 1.53, recorded on 24 April 2024 and 52-week low is AUD 1.068, recorded on 27 March 2025.

Support and Resistance Summary

Note 1: Past performance is neither an Indicator nor a guarantee of future performance.

Note 2: The reference date for all price data, and currency, is 02 April 2025. The reference data in this report has been partly sourced from EODHD/Others.

Technical Indicators Defined:

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.

Disclaimer

This article has been prepared by Kalkine Media, echoed on the website kalkinemedia.com/au and associated pages, based on the information obtained and collated from the subscription reports prepared by Kalkine Pty. Ltd. [ABN 34 154 808 312; AFSL no. 425376] on Kalkine.com.au (and associated pages). The principal purpose of the content is to provide factual information only for educational purposes. None of the content in this article, including any news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations, and video is or is intended to be, advisory in nature. The content does not contain or imply any recommendation or opinion intended to influence your financial decisions, including but not limited to, in respect of any particular security, transaction, or investment strategy, and must not be relied upon by you as such. The content is provided without any express or implied warranties of any kind. Kalkine Media, and its related bodies corporate, agents, and employees (Kalkine Group) cannot and do not warrant the accuracy, completeness, timeliness, merchantability, or fitness for a particular purpose of the content or the website, and to the extent permitted by law, Kalkine Group hereby disclaims any and all such express or implied warranties. Kalkine Group shall NOT be held liable for any investment or trading losses you may incur by using the information shared on our website.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (Kalkine Media, we or us), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.